FDA Inspection 1198249 — USpharma, Ltd.
The FDA completed an inspection of USpharma, Ltd. on February 16, 2023 in Miami Lakes, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Miami Lakes, FL (United States)